124 related articles for article (PubMed ID: 36087109)
41. Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study.
Burisch J; Pedersen N; Cukovic-Cavka S; Turk N; Kaimakliotis I; Duricova D; Bortlik M; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Ragnarsson G; Björnsson E; Bailey Y; O'Morain C; Schwartz D; Odes S; Giannotta M; Girardin G; Kiudelis G; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Martinez-Ares D; Hernandez V; Almer S; Zhulina Y; Halfvarson J; Arebi N; Tsai HH; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
J Crohns Colitis; 2014 Jul; 8(7):607-16. PubMed ID: 24315795
[TBL] [Abstract][Full Text] [Related]
42. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.
Müller KE; Lakatos PL; Arató A; Kovács JB; Várkonyi Á; Szűcs D; Szakos E; Sólyom E; Kovács M; Polgár M; Nemes É; Guthy I; Tokodi I; Tóth G; Horváth Á; Tárnok A; Csoszánszki N; Balogh M; Vass N; Bódi P; Dezsőfi A; Gárdos L; Micskey E; Papp M; Cseh Á; Szabó D; Vörös P; Veres G;
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399
[TBL] [Abstract][Full Text] [Related]
43. A comprehensive review and update on Crohn's disease.
Gajendran M; Loganathan P; Catinella AP; Hashash JG
Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
[TBL] [Abstract][Full Text] [Related]
44. Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.
Magro F; Rodrigues-Pinto E; Coelho R; Andrade P; Santos-Antunes J; Lopes S; Camila-Dias C; Macedo G
Am J Gastroenterol; 2014 Jul; 109(7):1026-36. PubMed ID: 24796767
[TBL] [Abstract][Full Text] [Related]
45. Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong.
Ng SC; Leung WK; Shi HY; Li MK; Leung CM; Ng CK; Lo FH; Hui YT; Tsang SW; Chan YK; Loo CK; Chan KH; Hui AJ; Chow WH; Harbord M; Ching JY; Lee M; Chan V; Tang W; Hung IF; Ho J; Lao WC; Wong MT; Sze SF; Shan EH; Lam BC; Tong RW; Mak LY; Wong SH; Wu JC; Chan FK; Sung JJ
Inflamm Bowel Dis; 2016 Aug; 22(8):1954-60. PubMed ID: 27416041
[TBL] [Abstract][Full Text] [Related]
46. Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001.
Lakatos L; Mester G; Erdelyi Z; Balogh M; Szipocs I; Kamaras G; Lakatos PL
World J Gastroenterol; 2004 Feb; 10(3):404-9. PubMed ID: 14760767
[TBL] [Abstract][Full Text] [Related]
47. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.
Jess T; Riis L; Vind I; Winther KV; Borg S; Binder V; Langholz E; Thomsen OØ; Munkholm P
Inflamm Bowel Dis; 2007 Apr; 13(4):481-9. PubMed ID: 17206705
[TBL] [Abstract][Full Text] [Related]
48. A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-07, showing increased incidence in Crohn's disease.
Perminow G; Brackmann S; Lyckander LG; Franke A; Borthne A; Rydning A; Aamodt G; Schreiber S; Vatn MH;
Scand J Gastroenterol; 2009; 44(4):446-56. PubMed ID: 19117240
[TBL] [Abstract][Full Text] [Related]
49. Temporal trends in non-stricturing and non-penetrating behaviour at diagnosis of Crohn's disease in Örebro, Sweden: a population-based retrospective study.
Zhulina Y; Udumyan R; Henriksson I; Tysk C; Montgomery S; Halfvarson J
J Crohns Colitis; 2014 Dec; 8(12):1653-60. PubMed ID: 25113899
[TBL] [Abstract][Full Text] [Related]
50. Pediatric inflammatory bowel disease: increasing incidence, decreasing surgery rate, and compromised nutritional status: A prospective population-based cohort study 2007-2009.
Jakobsen C; Paerregaard A; Munkholm P; Faerk J; Lange A; Andersen J; Jakobsen M; Kramer I; Czernia-Mazurkiewicz J; Wewer V
Inflamm Bowel Dis; 2011 Dec; 17(12):2541-50. PubMed ID: 21381152
[TBL] [Abstract][Full Text] [Related]
51. Smoking increases the risk of extraintestinal manifestations in Crohn's disease.
Ott C; Takses A; Obermeier F; Schnoy E; Müller M
World J Gastroenterol; 2014 Sep; 20(34):12269-76. PubMed ID: 25232261
[TBL] [Abstract][Full Text] [Related]
52. Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population-based cohort study.
Eriksson C; Henriksson I; Brus O; Zhulina Y; Nyhlin N; Tysk C; Montgomery S; Halfvarson J
Aliment Pharmacol Ther; 2018 Sep; 48(6):638-645. PubMed ID: 30069892
[TBL] [Abstract][Full Text] [Related]
53. Clinical course of Crohn's disease during the first 5 years. Results from a population-based cohort in Sweden (ICURE) diagnosed 2005-2009
Rönnblom A; Holmström T; Karlbom U; Tanghöj H; Thörn M; Sjöberg D
Scand J Gastroenterol; 2017 Jan; 52(1):81-86. PubMed ID: 27632773
[TBL] [Abstract][Full Text] [Related]
54. Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort.
Vegh Z; Burisch J; Pedersen N; Kaimakliotis I; Duricova D; Bortlik M; Vinding KK; Avnstrøm S; Olsen J; Nielsen KR; Katsanos KH; Tsianos EV; Lakatos L; Schwartz D; Odes S; D'Incà R; Beltrami M; Kiudelis G; Kupcinskap L; Jucov A; Turcan S; Barros LF; Magro F; Lazar D; Goldis A; de Castro L; Hernandez V; Niewiadomski O; Bell S; Langholz E; Munkholm P; Lakatos PL;
J Crohns Colitis; 2015 Sep; 9(9):747-53. PubMed ID: 26055976
[TBL] [Abstract][Full Text] [Related]
55. Evolution of Clinical Behavior in Crohn's Disease: Factors Associated with Complicated Disease and Surgery.
de Barros KSC; Flores C; Harlacher L; Francesconi CFM
Dig Dis Sci; 2017 Sep; 62(9):2481-2488. PubMed ID: 28748409
[TBL] [Abstract][Full Text] [Related]
56. The Incidence and Disease Course of Perianal Crohn's Disease: A Danish Nationwide Cohort Study, 1997-2015.
Wewer MD; Zhao M; Nordholm-Carstensen A; Weimers P; Seidelin JB; Burisch J
J Crohns Colitis; 2021 Jan; 15(1):5-13. PubMed ID: 32582937
[TBL] [Abstract][Full Text] [Related]
57. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Wang Y; MacDonald JK; Hanauer S
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008870. PubMed ID: 27372735
[TBL] [Abstract][Full Text] [Related]
58. A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986-2015.
Park SH; Kim YJ; Rhee KH; Kim YH; Hong SN; Kim KH; Seo SI; Cha JM; Park SY; Jeong SK; Lee JH; Park H; Kim JS; Im JP; Yoon H; Kim SH; Jang J; Kim JH; Suh SO; Kim YK; Ye BD; Yang SK;
J Crohns Colitis; 2019 Oct; 13(11):1410-1417. PubMed ID: 30989166
[TBL] [Abstract][Full Text] [Related]
59. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
60. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
Gjuladin-Hellon T; Gordon M; Iheozor-Ejiofor Z; Akobeng AK
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD008414. PubMed ID: 31220875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
